·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÀÌ¹Î¾Æ ¼øÃµ¾à´ë ±³¼ö, ´ëÇйßÀü±â±Ý 1õ¸¸¿ø ±âŹ ±â»çÀÔ·Â : 23.11.03 21:29:54 0 °¡ ÇÃÄ£Ãß°¡ "±Û·ÎÄôëÇÐ30 ¼±Á¤ ¿°¿ø¡¦Áö¡¤»ê¡¤ÇÐ µ¿¹Ý¼ºÀå ±â´ë" [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¼øÃµ´ëÇб³ ¾àÇаú ÀÌ¹Î¾Æ ±³¼ö°¡ ´ëÇйßÀü±â±ÝÀ¸·Î 1õ¸¸¿øÀ» ±âŹÇß´Ù. ±¹¸³ ¼øÃµ´ëÇб³(ÃÑÀå À̺´¿î)´Â ¹ÙÀÌ¿À¸Þ±âÄñ۷ιú»ç¾÷´Ü°ú °øµ¿½ÇÇè½Ç½À°üÀåÀ» ¸Ã°í ÀÖ´Â ¾àÇаú ÀÌ¹Î¾Æ ±³¼ö°¡ Çб³ ¹ßÀüÀ» À§ÇØ ´ëÇйßÀü±â±ÝÀ» ±âŹÇß´Ù°í ¹àÇû´Ù. ÀÌ ±³¼ö´Â "±Û·ÎÄôëÇÐ30 ÃÖÁ¾ ¼±Á¤¿¡ ´ëÇÑ ¿°¿øÀ» ´ã¾Æ ¹ßÀü±â±ÝÀ» ±âŹÇÏ°Ô µÆ´Ù"¸ç "±Û·ÎÄôëÇÐ30 »ç¾÷À» ±â¹ÝÀ¸·Î °¼ÒÁö¿ª±â¾÷°ú ÇÔ²² Áö¿ª»çȸ¿Í ´ëÇÐÀÌ µ¿¹Ý ¼ºÀåÇÏ±æ ±â´ëÇÑ´Ù"°í ÀüÇß´Ù. À̺´¿î ÃÑÀåÀº "Áö¡¤»ê¡¤ÇÐ Çù·ÂÀÌ ±Û·ÎÄà ¼øÃµ´ëÇб³ÀÇ ÇÙ½ÉÀÌÀÚ µ¿¹Ý¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °Í"À̶ó¸ç "¿ì¸® ´ëÇÐ ±¸¼º¿øµéÀÇ Å« °ü½É°ú »ç¶û¿¡ °¨»çµå¸®¸ç µ¿¹Ý¼ºÀåÀÇ ²ÞÀ» °°ÀÌ ÀÌ·ï ³ª°¬À¸¸é ÇÑ´Ù"°í ¸»Çß´Ù. ÇÑÆí ÀÌ¹Î¾Æ ±³¼ö´Â õ¿¬¹°ÈÇÐ Àü°øÀ¸·Î Çлýµé¿¡°Ô õ¿¬¹°¾àǰÇÐ, ÇѾàÁ¦Á¦ÇÐÀ» °¡¸£Ä¡°í ÀÖÀ¸¸ç »ê¾÷Åë»óÀÚ¿øºÎ '¹ÙÀÌ¿À¸ÞµðÄà R&D ±â¹Ý ±Û·Î¹ú ÁøÃâ Áö¿ø»ç¾÷' ¼öÇàÀ¸·Î Áö¿ª±â¾÷ ¼ö¿ä ¸ÂÃãÇü ±â¼úÁö¿øÀ» ÅëÇÑ ÇØ¿Ü ¼öÃâ È®´ë¿¡ ±â¿©Çϰí ÀÖ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÌ¹Î¾Æ ¼øÃµ¾à´ë ±³¼ö, ´ëÇйßÀü±â±Ý 1õ¸¸¿ø ±âŹ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀÌ¹Î¾Æ ¼øÃµ¾à´ë ±³¼ö, ´ëÇйßÀü±â±Ý 1õ¸¸¿ø ±âŹ ±â»çÀÔ·Â : 23.11.03 21:29:54 0 °¡ ÇÃÄ£Ãß°¡ "±Û·ÎÄôëÇÐ30 ¼±Á¤ ¿°¿ø¡¦Áö¡¤»ê¡¤ÇÐ µ¿¹Ý¼ºÀå ±â´ë" [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¼øÃµ´ëÇб³ ¾àÇаú ÀÌ¹Î¾Æ ±³¼ö°¡ ´ëÇйßÀü±â±ÝÀ¸·Î 1õ¸¸¿øÀ» ±âŹÇß´Ù. ±¹¸³ ¼øÃµ´ëÇб³(ÃÑÀå À̺´¿î)´Â ¹ÙÀÌ¿À¸Þ±âÄñ۷ιú»ç¾÷´Ü°ú °øµ¿½ÇÇè½Ç½À°üÀåÀ» ¸Ã°í ÀÖ´Â ¾àÇаú ÀÌ¹Î¾Æ ±³¼ö°¡ Çб³ ¹ßÀüÀ» À§ÇØ ´ëÇйßÀü±â±ÝÀ» ±âŹÇß´Ù°í ¹àÇû´Ù. ÀÌ ±³¼ö´Â "±Û·ÎÄôëÇÐ30 ÃÖÁ¾ ¼±Á¤¿¡ ´ëÇÑ ¿°¿øÀ» ´ã¾Æ ¹ßÀü±â±ÝÀ» ±âŹÇÏ°Ô µÆ´Ù"¸ç "±Û·ÎÄôëÇÐ30 »ç¾÷À» ±â¹ÝÀ¸·Î °¼ÒÁö¿ª±â¾÷°ú ÇÔ²² Áö¿ª»çȸ¿Í ´ëÇÐÀÌ µ¿¹Ý ¼ºÀåÇÏ±æ ±â´ëÇÑ´Ù"°í ÀüÇß´Ù. À̺´¿î ÃÑÀåÀº "Áö¡¤»ê¡¤ÇÐ Çù·ÂÀÌ ±Û·ÎÄà ¼øÃµ´ëÇб³ÀÇ ÇÙ½ÉÀÌÀÚ µ¿¹Ý¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °Í"À̶ó¸ç "¿ì¸® ´ëÇÐ ±¸¼º¿øµéÀÇ Å« °ü½É°ú »ç¶û¿¡ °¨»çµå¸®¸ç µ¿¹Ý¼ºÀåÀÇ ²ÞÀ» °°ÀÌ ÀÌ·ï ³ª°¬À¸¸é ÇÑ´Ù"°í ¸»Çß´Ù. ÇÑÆí ÀÌ¹Î¾Æ ±³¼ö´Â õ¿¬¹°ÈÇÐ Àü°øÀ¸·Î Çлýµé¿¡°Ô õ¿¬¹°¾àǰÇÐ, ÇѾàÁ¦Á¦ÇÐÀ» °¡¸£Ä¡°í ÀÖÀ¸¸ç »ê¾÷Åë»óÀÚ¿øºÎ '¹ÙÀÌ¿À¸ÞµðÄà R&D ±â¹Ý ±Û·Î¹ú ÁøÃâ Áö¿ø»ç¾÷' ¼öÇàÀ¸·Î Áö¿ª±â¾÷ ¼ö¿ä ¸ÂÃãÇü ±â¼úÁö¿øÀ» ÅëÇÑ ÇØ¿Ü ¼öÃâ È®´ë¿¡ ±â¿©Çϰí ÀÖ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÌ¹Î¾Æ ¼øÃµ¾à´ë ±³¼ö, ´ëÇйßÀü±â±Ý 1õ¸¸¿ø ±âŹ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀÌ¹Î¾Æ ¼øÃµ¾à´ë ±³¼ö, ´ëÇйßÀü±â±Ý 1õ¸¸¿ø ±âŹ ±â»çÀÔ·Â : 23.11.03 21:29:54 0 °¡ ÇÃÄ£Ãß°¡ "±Û·ÎÄôëÇÐ30 ¼±Á¤ ¿°¿ø¡¦Áö¡¤»ê¡¤ÇÐ µ¿¹Ý¼ºÀå ±â´ë" [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ¼øÃµ´ëÇб³ ¾àÇаú ÀÌ¹Î¾Æ ±³¼ö°¡ ´ëÇйßÀü±â±ÝÀ¸·Î 1õ¸¸¿øÀ» ±âŹÇß´Ù. ±¹¸³ ¼øÃµ´ëÇб³(ÃÑÀå À̺´¿î)´Â ¹ÙÀÌ¿À¸Þ±âÄñ۷ιú»ç¾÷´Ü°ú °øµ¿½ÇÇè½Ç½À°üÀåÀ» ¸Ã°í ÀÖ´Â ¾àÇаú ÀÌ¹Î¾Æ ±³¼ö°¡ Çб³ ¹ßÀüÀ» À§ÇØ ´ëÇйßÀü±â±ÝÀ» ±âŹÇß´Ù°í ¹àÇû´Ù. ÀÌ ±³¼ö´Â "±Û·ÎÄôëÇÐ30 ÃÖÁ¾ ¼±Á¤¿¡ ´ëÇÑ ¿°¿øÀ» ´ã¾Æ ¹ßÀü±â±ÝÀ» ±âŹÇÏ°Ô µÆ´Ù"¸ç "±Û·ÎÄôëÇÐ30 »ç¾÷À» ±â¹ÝÀ¸·Î °¼ÒÁö¿ª±â¾÷°ú ÇÔ²² Áö¿ª»çȸ¿Í ´ëÇÐÀÌ µ¿¹Ý ¼ºÀåÇÏ±æ ±â´ëÇÑ´Ù"°í ÀüÇß´Ù. À̺´¿î ÃÑÀåÀº "Áö¡¤»ê¡¤ÇÐ Çù·ÂÀÌ ±Û·ÎÄà ¼øÃµ´ëÇб³ÀÇ ÇÙ½ÉÀÌÀÚ µ¿¹Ý¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °Í"À̶ó¸ç "¿ì¸® ´ëÇÐ ±¸¼º¿øµéÀÇ Å« °ü½É°ú »ç¶û¿¡ °¨»çµå¸®¸ç µ¿¹Ý¼ºÀåÀÇ ²ÞÀ» °°ÀÌ ÀÌ·ï ³ª°¬À¸¸é ÇÑ´Ù"°í ¸»Çß´Ù. ÇÑÆí ÀÌ¹Î¾Æ ±³¼ö´Â õ¿¬¹°ÈÇÐ Àü°øÀ¸·Î Çлýµé¿¡°Ô õ¿¬¹°¾àǰÇÐ, ÇѾàÁ¦Á¦ÇÐÀ» °¡¸£Ä¡°í ÀÖÀ¸¸ç »ê¾÷Åë»óÀÚ¿øºÎ '¹ÙÀÌ¿À¸ÞµðÄà R&D ±â¹Ý ±Û·Î¹ú ÁøÃâ Áö¿ø»ç¾÷' ¼öÇàÀ¸·Î Áö¿ª±â¾÷ ¼ö¿ä ¸ÂÃãÇü ±â¼úÁö¿øÀ» ÅëÇÑ ÇØ¿Ü ¼öÃâ È®´ë¿¡ ±â¿©Çϰí ÀÖ´Ù. X AD Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀÌ¹Î¾Æ ¼øÃµ¾à´ë ±³¼ö, ´ëÇйßÀü±â±Ý 1õ¸¸¿ø ±âŹ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö